LÖFGREN’S SYNDROME: ASSESSMENT OF OUTCOMES


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The clinical features and outcomes of erythema nodosum were studied in patients with Löfgren’s syndrome.

Full Text

Restricted Access

About the authors

N. Savushkina

V.A. Nasonova Research Institute of Rheumatology

Email: savushkinanm@mail.ru

O. Egorova

V.A. Nasonova Research Institute of Rheumatology

Candidate of Medical Sciences

S. Glukhova

V.A. Nasonova Research Institute of Rheumatology

Candidate of Medical Sciences

S. Radenska-Lopovok

V.A. Nasonova Research Institute of Rheumatology

B. Belov

V.A. Nasonova Research Institute of Rheumatology

References

  1. Lazarus A. Sarcoidosis: epidemiology, etiology, pathogenesis, and genetics // Dis. Mon. - 2009; 55: 649-60.
  2. Hanno R., Callen J. Sarcoidosis: a disorder with prominent cutaneous features and their interrelationship with systemic disease // Med. Clin. North. Am. - 1980; 64: 847-66.
  3. Mana J., Marcoval J. Skin manifestations of sarcoidosis // Presse Med. -2012; 41: 355-74.
  4. Parrish S., Turner J. Diagnosis of sarcoidosis // Dis. Mon. - 2009; 55: 693-703.
  5. Mana J., Gomez-Vaquero C., Montero A. et al. Lofgren’s syndrome revisited: a study of 186 patients // Am. J. Med. - 1999; 107: 240-5.
  6. Löfgren S., Lundbäck H. The bilateral hilar lymphoma syndrome. A study of the relation to age and sex in 212 cases // Acta Med. Scand. - 1952; 142: 259-64.
  7. Mana J., Marcoval J. Erythema nodosum // Clin. Dermatol. - 2007; 25: 288-94.
  8. Mana J., Marcoval J., Graells J. et al. Cutaneous involvement in sarcoidosis. Relationship to systemic disease // Arch. Dermatol. - 1997; 133: 882-8.
  9. Paramothayan N., Jones P. Corticosteroids for pulmonary sarcoidosis // Cochrane Database Syst. Rev. - 2000; 2: CD001114.
  10. Hunninghake G., Costabel U., Ando M. et al. ATS/ ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/ World Association of Sarcoidosis and other Granulomatous Disorders // Sarcoidosis Vasc. Diffuse Lung Dis. - 1999; 16 (2): 149-73.
  11. Чучалин А.Г., Авдеев С.Н., Баранова О.П. и др. Диагностика и лечение саркоидоза (Федеральные согласительные клинические рекомендации) / Минздрав России. Российское респираторное общество, 2014; с. 36-9.
  12. Ungprasert P., Carmona E., Utz J. et al. Epidemiology of Sarcoidosis 19462013: A Population-Based Study // Mayo Clin. Proc. - 2016; 91 (2): 183-8.
  13. Tejera Segura B., Holgado S., Mateo L. et al. Löfgren syndrome: A study of 80 cases // Medicina Clinica. - 2014; 143 (4): 166-9.
  14. Mana J., Salazar A., Manresa F. Clinical factors predicting persistence of activity in sarcoidosis: a multivariate analysis of 193 cases // Respiration. - 1994; 61 (4): 219-25.
  15. Takada K., Ina Y., Noda M. et al. The clinical course and prognosis of patients with severe, moderate or mild sarcoidosis // J. Clin. Epidemiol. - 1993; 46 (4): 359-66.
  16. Визель И.Ю., Шмелев Е.И., Баранова О.П. и др. Мультицентровой ретроспективный анализ состояния больных саркоидозом с 10-летним интервалом наблюдения // Клиническая медицина. - 2014; 92 (6): 28-34.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies